0001104659-23-006184.txt : 20230124 0001104659-23-006184.hdr.sgml : 20230124 20230124160500 ACCESSION NUMBER: 0001104659-23-006184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230120 FILED AS OF DATE: 20230124 DATE AS OF CHANGE: 20230124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brenner Martin CENTRAL INDEX KEY: 0001770235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 23548175 MAIL ADDRESS: STREET 1: C/O PFENEX INC. STREET 2: 10790 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 4 1 tm234222-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-20 0 0001420720 iBio, Inc. IBIO 0001770235 Brenner Martin C/O IBIO, INC., 8800 HSC PARKWAY BRYAN TX 77807 0 1 0 0 Interim CEO and CSO Common Stock 2023-01-20 4 A 0 130000 0 A 225348 D Consists of 130,000 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 130,000 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 130,000 RSUs vest pro rata over a twelve- month period, such vesting to terminate if Dr. Brenner is no longer the Company's Interim Chief Executive Officer. /s/ Martin Brenner 2023-01-24